288TiPA randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
McArthur, H L, Comen, E A, Bryce, Y, Solomon, S B, Leal, J H S, Rodine, M, Abaya, C D, Patil, S, Page, D B, Norton, LVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz240.111
Date:
October, 2019
File:
PDF, 82 KB
english, 2019